Advertisement

Index by author

March 01, 1989; Volume 35,Issue 3

A

  1. Ambler, S K

    1. Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
      S K Ambler and P Taylor
      Molecular Pharmacology March 1989, 35 (3) 369-374;

B

  1. Baur, R

    1. The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;

  2. Behrendt, J

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

  3. Boulay, G

    1. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;

  4. Bristow, M R

    1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

  5. Brodde, O E

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

D

  1. Dingledine, R

    1. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

E

  1. Eens, A

    1. Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

F

  1. Feldman, R D

    1. Beta-adrenergic desensitization reduces the sensitivity of adenylate cyclase for magnesium in permeabilized lymphocytes.
      R D Feldman
      Molecular Pharmacology March 1989, 35 (3) 304-310;

G

  1. Galitzky, J

    1. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;

  2. Guillemette, G

    1. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;

  3. Guzelian, P S

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

H

  1. Haga, K

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

  2. Haga, T

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

  3. Halm, E

    1. Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;

  4. Heasley, L E

    1. Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
      L E Heasley and G L Johnson
      Molecular Pharmacology March 1989, 35 (3) 331-338;

  5. Hershberger, R E

    1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

  6. Hostetler, K A

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

I

  1. Ichiyama, A

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

  2. Insel, P A

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

J

  1. Janssen, P A

    1. Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

  2. Johnson, G L

    1. Detection of nerve growth factor and epidermal growth factor-regulated protein kinases in PC12 cells with synthetic peptide substrates.
      L E Heasley and G L Johnson
      Molecular Pharmacology March 1989, 35 (3) 331-338;

  3. Joseph, S K

    1. The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
      S K Joseph and H L Rice
      Molecular Pharmacology March 1989, 35 (3) 355-359;

K

  1. Kangawa, K

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

  2. Kleckner, N W

    1. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

L

  1. Lamontagne, S

    1. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;

  2. Levin, W

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

  3. Leysen, J E

    1. Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

M

  1. Manganiello, V C

    1. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
      C J Smith and V C Manganiello
      Molecular Pharmacology March 1989, 35 (3) 381-386;

  2. Matsuo, H

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

  3. Michel, M C

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

  4. Minobe, W

    1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

  5. Mitsuhashi, M

    1. Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
      M Mitsuhashi and D G Payan
      Molecular Pharmacology March 1989, 35 (3) 311-318;

  6. Molowa, D T

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

  7. Motulsky, H J

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

  8. Mouillac, B

    1. Differential effects of heparin on inositol 1,4,5-trisphosphate binding, metabolism, and calcium release activity in the bovine adrenal cortex.
      G Guillemette, S Lamontagne, G Boulay and B Mouillac
      Molecular Pharmacology March 1989, 35 (3) 339-344;

N

  1. Nestler, E J

    1. Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;

P

  1. Paris, H

    1. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;

  2. Payan, D G

    1. Receptor glycosylation regulates the affinity of histamine H1 receptors during smooth muscle cell differentiation.
      M Mitsuhashi and D G Payan
      Molecular Pharmacology March 1989, 35 (3) 311-318;

  3. Peter, A B

    1. The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;

  4. Politi, P M

    1. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
      P M Politi and B K Sinha
      Molecular Pharmacology March 1989, 35 (3) 271-278;

  5. Port, J D

    1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

R

  1. Rasmussen, R

    1. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
      M R Bristow, R E Hershberger, J D Port, W Minobe and R Rasmussen
      Molecular Pharmacology March 1989, 35 (3) 295-303;

  2. Rice, H L

    1. The relationship between inositol trisphosphate receptor density and calcium release in brain microsomes.
      S K Joseph and H L Rice
      Molecular Pharmacology March 1989, 35 (3) 355-359;

S

  1. Schnepel, B

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

  2. Senard, J M

    1. Interactions of full and partial agonists with HT29 cell alpha 2-adrenoceptor: comparative study of [3H]UK-14,304 and [3H]clonidine binding.
      H Paris, J Galitzky and J M Senard
      Molecular Pharmacology March 1989, 35 (3) 345-354;

  3. Sigel, E

    1. The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;

  4. Sinha, B K

    1. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
      P M Politi and B K Sinha
      Molecular Pharmacology March 1989, 35 (3) 271-278;

  5. Smith, C J

    1. Role of hormone-sensitive low Km cAMP phosphodiesterase in regulation of cAMP-dependent protein kinase and lipolysis in rat adipocytes.
      C J Smith and V C Manganiello
      Molecular Pharmacology March 1989, 35 (3) 381-386;

T

  1. Taylor, P

    1. Release of nonmitochondrial sequestered Ca2+ from permeabilized muscle cells in culture.
      S K Ambler and P Taylor
      Molecular Pharmacology March 1989, 35 (3) 369-374;

  2. Terwilliger, R Z

    1. Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain.
      E J Nestler, R Z Terwilliger and E Halm
      Molecular Pharmacology March 1989, 35 (3) 265-270;

  3. Thomas, P E

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

  4. Tschada, R

    1. [3H]idazoxan and some other alpha 2-adrenergic drugs also bind with high affinity to a nonadrenergic site.
      M C Michel, O E Brodde, B Schnepel, J Behrendt, R Tschada, H J Motulsky and P A Insel
      Molecular Pharmacology March 1989, 35 (3) 324-330;

U

  1. Uchiyama, H

    1. Cerebral muscarinic acetylcholine receptors interact with three kinds of GTP-binding proteins in a reconstitution system of purified components.
      K Haga, H Uchiyama, T Haga, A Ichiyama, K Kangawa and H Matsuo
      Molecular Pharmacology March 1989, 35 (3) 286-294;

V

  1. Verdoorn, T A

    1. N-methyl-D-aspartate/glycine and quisqualate/kainate receptors expressed in Xenopus oocytes: antagonist pharmacology.
      T A Verdoorn, N W Kleckner and R Dingledine
      Molecular Pharmacology March 1989, 35 (3) 360-368;

W

  1. Wrighton, S A

    1. Coinduction of multiple hepatic cytochrome P-450 proteins and their mRNAs in rats treated with imidazole antimycotic agents.
      K A Hostetler, S A Wrighton, D T Molowa, P E Thomas, W Levin and P S Guzelian
      Molecular Pharmacology March 1989, 35 (3) 279-285;

  2. Wynants, J

    1. Ketanserin reduces a particular monoamine pool in peripheral tissues.
      J E Leysen, J Wynants, A Eens and P A Janssen
      Molecular Pharmacology March 1989, 35 (3) 375-380;

Y

  1. Yao, Y

    1. The tremorigen aflatrem is a positive allosteric modulator of the gamma-aminobutyric acidA receptor channel expressed in Xenopus oocytes.
      Y Yao, A B Peter, R Baur and E Sigel
      Molecular Pharmacology March 1989, 35 (3) 319-323;
Back to top

In this issue

Advertisement